These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6287202)

  • 21. [Action of calcium antagonists on thrombocyte aggregation].
    Lakin KM; Manevich EM; Muliar AG; Mironiuk EP; Novikova NV
    Farmakol Toksikol; 1987; 50(5):78-88. PubMed ID: 2826225
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired cAMP metabolism associated with abnormal function of thrombopathic canine platelets.
    Boudreaux MK; Dodds WJ; Slauson DO; Catalfamo JL
    Biochem Biophys Res Commun; 1986 Oct; 140(2):595-601. PubMed ID: 2430569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of forskolin on primary cultures of astrocytes and oligodendrocytes.
    Wu DK; de Vellis J
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(1):59-67. PubMed ID: 6315794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of hispidulin, a natural flavone, on human platelets.
    Bourdillat B; Delautier D; Labat C; Benveniste J; Potier P; Brink C
    Prog Clin Biol Res; 1988; 280():211-4. PubMed ID: 2845433
    [No Abstract]   [Full Text] [Related]  

  • 25. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.
    Hoet B; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1993 Nov; 70(5):822-5. PubMed ID: 8128441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
    Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
    Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prostaglandins on function and cyclic AMP levels of human blood platelets.
    Robison G; Cole B; Arnold A; Hartmann R
    Ann N Y Acad Sci; 1971 Apr; 180():324-31. PubMed ID: 4329031
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of human platelet aggregation by motapizone via an increase in intracellular cAMP.
    Borbe HO; Hilboll G; Prop G
    Agents Actions Suppl; 1986; 20():249-57. PubMed ID: 3028104
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control mechanisms in platelet activation.
    Fritsma G; Engelmann G; Yousuf M
    Am J Med Technol; 1981 Oct; 47(10):813-8. PubMed ID: 6277193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and impairment of platelet function in vitro by fatty acid ethyl ester, a nonoxidative ethanol metabolite: effect of fatty acid ethyl esters on human platelets.
    Salem RO; Laposata M
    Alcohol Clin Exp Res; 2006 Dec; 30(12):2079-88. PubMed ID: 17117973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostaglandins and platelet function].
    Juan H
    Acta Med Austriaca Suppl; 1982; 25():37-43. PubMed ID: 6958155
    [No Abstract]   [Full Text] [Related]  

  • 35. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pentoxifylline and prostaglandins].
    Poggesi L; Boddi M; Scarti L; Masotti G
    Ric Clin Lab; 1988; 18 Suppl 2():37-46. PubMed ID: 2854659
    [No Abstract]   [Full Text] [Related]  

  • 37. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation.
    Bae ON; Kim YD; Lim KM; Noh JY; Chung SM; Kim K; Hong S; Shin S; Yoon JH; Chung JH
    Thromb Haemost; 2008 Jul; 100(1):52-9. PubMed ID: 18612538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal and forskolin-stimulated cyclic adenosine monophosphate in intact human platelets during the menstrual cycle.
    Pansini F; Piccolo R; Bassi P; Guzzinati N; Jacobs M; Ambrosecchia R; Bergamini C; Mollica G
    Am J Obstet Gynecol; 1986 Mar; 154(3):679-82. PubMed ID: 3006496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium modifies the responses of platelets to inhibitory agents which act via cAMP.
    Hardy E; Glenn J; Heptinstall S; Rubin PC; Horn EH
    Thromb Haemost; 1995 Oct; 74(4):1132-7. PubMed ID: 8560425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.